pargyline has been researched along with Paralysis in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, SY | 1 |
| Goshgarian, HG | 1 |
| Simpson, LL | 1 |
| Tapp, JT | 1 |
2 other studies available for pargyline and Paralysis
| Article | Year |
|---|---|
Effects of serotonin on crossed phrenic nerve activity in cervical spinal cord hemisected rats.
Topics: 5-Hydroxytryptophan; Animals; Asphyxia; Cervical Vertebrae; Female; Functional Laterality; Methyserg | 1999 |
Partial antagonism of experimental botulinal intoxication.
Topics: Animals; Antitoxins; Calcium; Clostridium botulinum; Diaphragm; Drug Antagonism; Female; In Vitro Te | 1967 |